1078 related articles for article (PubMed ID: 18511133)
21. Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus.
Jiang W; Jiang P; Wang X; Li Y; Du Y; Wang X
Virus Res; 2008 Sep; 136(1-2):50-7. PubMed ID: 18538882
[TBL] [Abstract][Full Text] [Related]
22. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
Zhou G; Wang H; Wang F; Yu L
Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
[TBL] [Abstract][Full Text] [Related]
23. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
24. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
25. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs.
Li J; Jiang P; Li Y; Wang X; Cao J; Wang X; Zeshan B
Vaccine; 2009 Feb; 27(6):825-32. PubMed ID: 19070639
[TBL] [Abstract][Full Text] [Related]
26. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
Yao Q; Qian P; Huang Q; Cao Y; Chen H
J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
[TBL] [Abstract][Full Text] [Related]
27. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
de Avila Botton S; Brum MC; Bautista E; Koster M; Weiblen R; Golde WT; Grubman MJ
Vaccine; 2006 Apr; 24(17):3446-56. PubMed ID: 16522345
[TBL] [Abstract][Full Text] [Related]
28. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
[TBL] [Abstract][Full Text] [Related]
29. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
Wang X; Jiang P; Li Y; Jiang W; Dong X
Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
[TBL] [Abstract][Full Text] [Related]
31. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
Fowler VL; Knowles NJ; Paton DJ; Barnett PV
Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
[TBL] [Abstract][Full Text] [Related]
32. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus.
Li YG; Tian FL; Gao FS; Tang XS; Xia C
Vaccine; 2007 Jan; 25(5):902-11. PubMed ID: 17028078
[TBL] [Abstract][Full Text] [Related]
33. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
35. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
[TBL] [Abstract][Full Text] [Related]
36. A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine.
Song H; Wang Z; Zheng D; Fang W; Li Y; Liu Y; Niu Z; Qiu B
Biotechnol Lett; 2005 Nov; 27(21):1669-74. PubMed ID: 16247672
[TBL] [Abstract][Full Text] [Related]
37. [Enhancement of mouse immune response by recombinant adenovirus co-expressing VP1-2A of foot-and-mouth disease virus and porcine IFN-α].
Su C; Duan X; Cao R; Zheng J; Chen P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1129-32. PubMed ID: 25374073
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
[TBL] [Abstract][Full Text] [Related]
39. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
[TBL] [Abstract][Full Text] [Related]
40. [Enhanced immune response of a novel T-cell immunogen in vaccine for foot-and-mouth disease].
Zhao Q; Sun P; Liu Z; Li P; Bao H; Cao Y; Bai X; Fu Y; Lu Z; Li D
Sheng Wu Gong Cheng Xue Bao; 2011 Sep; 27(9):1281-91. PubMed ID: 22117511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
